SSCI Offers Benchmarks As Gatekeepers For Supplements To Reach Retail Shelves
Executive Summary
FDA’s GMP final rule set uniform standards to ensure quality throughout manufacturing, packaging, labeling and holding of supplements, but Supplement Safety and Compliance Initiative says manufacturing practices continue to vary widely across the industry and the agency cannot inspect every facility. “FDA can’t solve all our problems. I don’t know if FDA knows the number of facilities it needs to inspect to ensure consumer confidence," says Daniel Fabricant, president of SSCI member NPA.
You may also be interested in...
US Process Modeled On OTC Review Could Improve Supplement Health Claim Requests’ Chances
Claims supplements could be stronger, says a veteran food and supplement industry attorney, if FDA would give appropriate credit to the scientific evidence that firms are providing with their requests to use unqualified health claims.
FDA Slacking In NDI Notification Enforcement; COVID-19 'Is Not An Excuse’ – NPA
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
FDA Dietary Supplement Programs Research, Strategy Official Moves To NPA
Sibyl Swift is responsible for developing and implementing NPA's educational, regulatory and compliance programs such as SSCI and the NPA Natural Standard. She also will assist members with claim reviews, substantiation and NDI notification policy.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: